Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew and updated entries for Study Status appear in the history, showing changes to the trial's recruitment and status on recent dates.SummaryDifference0.3%

- Check15 days agoChange DetectedThe record history now includes Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedRevision history shows the new release v3.3.2 and removes the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedDeleted the administrative funding/operating-status notice that warned about updates due to appropriations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check65 days agoChange DetectedThe Record History page UI appears refreshed in the new screenshot, but the version list and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page has updated operating status messaging and a new version/revision now shown as v3.2.0 dated 2025-10-03, replacing the older v3.1.0 from 2025-06-17.SummaryDifference12%

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.